The prominent Philadelphia online news publication www.Philly.com has recently published an article investigating the safety of the popular anticoagulant drug, Pradaxa. While medical researchers have already described the increased risk for heart attack associated with Pradaxa use, this article by Michael Cohen discusses new findings that have shown Pradaxa may cause internal bleeding in elderly patients…. Continue Reading
Category Archives: Drugs
Subscribe to Drugs RSS FeedPradaxa Found To Raise Risk of Heart Attack, Reuters Reports
Posted in Misc. DrugsRecently, Reuters News has reported on serious risks associated with a popular anticoagulant drug, Pradaxa. In particular, medical researchers have found that Pradaxa use dramatically raises risk of heart attack in some people. For more information, read the full report on Pradaxa and heart attack here.
AAJ on Generic Preemption
Posted in FDA Regulation, Generic DrugsHere’s a little more in-depth analysis of the generic drug argument before SCOTUS: Andre Mura, litigation counsel at the Center for Constitutional Litigation in Washington, D.C., said the government’s argument was troubling. “There were suggestions that the FDA shouldn’t be second-guessed, but as the Court said in Wyeth v. Levine, the FDA approval process does… Continue Reading
DailyRx.com Reports on Danger of Zithromax Z-Pak
Posted in Misc. DrugsA recent article published by DailyRx.com, a prominent pharmaceutical commentary website, has commented on FDA warnings that Zithromax Z-Pak can cause fatal heart rhythms, and suggests that potential users of the drug be very cautious. The author of the article, Dr. Sarah Samaan, writes: “Patients at particular risk for developing a potentially deadly irregular heart… Continue Reading
FDA Calls for Zithromax Warning Label Update
Posted in Misc. DrugsRecently, the United States Food and Drug Administration has required that the warning label for the popular antibiotic drug Zithromax be updated to include information regarding the drug’s likelihood to cause cardiovascular death. Some studies have shown that the drug raises the risk for cardiovascular death by a factor of 2.5, compared with other antibiotic… Continue Reading
Zithromax Z-Pak Causes Fatal Heart Rhythms
Posted in Misc. DrugsCNN reports that the popular antibiotic drug azithromycin, marked under the brand name Zithromaz Z-Pak, can cause fatal arrhythmia in its users. Read more on how Zithromax Z-Pak causes cardiovascular death by reading the CNN report.
Zithromax Z-Pak Causes Heart Attack, FDA Reports
Posted in Misc. DrugsRecently, the United States Food and Drug Administration has reported on the danger of the popular antibiotic Zithromax Z-Pak and its tendency to increase risk for sudden cardiovascular failure at least 2.5-fold. Read the full FDA report, the publication of which resulted in a required alteration of the Zithromax Z-Pak warning label.
CNN Describes Danger of Zithromax Z-Pak
Posted in Misc. DrugsReporting by CNN marks further citation of the danger associated with Zithromax Z-Pak, a popular antibiotic. This and other news articles and scientific studies confirm that use of Zithromax Z-Pak raises risk of heart attack by at least two and a half times.
New York Times Cites Danger of Zithromax Z-Pak
Posted in Misc. DrugsA recent article published in the New York Times describes the newly-confirmed danger of the popular antibiotic drug Zithromax Z-Pak, citing that use of the drug dramatically raises one’s risk for sudden cardiovascular death. Read New York Times reporter Denise Grady’s account of heart attack caused by Zithromax Z-Pak here.
Alarm Caused by New Zithromax Z-Pak Warning Labels
Posted in Misc. DrugsThe website The Examiner cites alarm caused by the newly-changed warning labels for the popular antibiotic drug Zithromax Z-Pak, which has recently been found to dramatically raise the risk for sudden cardiac arrest in users. Read the full, in depth report of the connection between Zithromax use and heart attack here.
Zithromax Warning Update, ABC News Reports
Posted in Misc. DrugsCiting a warning by the FDA and a study published in the New England Journal of Medicine that reported the Zithromax Z-Pak antibiotic raises the risk for sudden cardiovascular death by a factor of 2.5 over other antibiotics, ABC news reports that the US federal government has required the labels of Zithromax Z-Pak be changed to include… Continue Reading
Zithromax Z-Pak Causes Cardiac Arrest in 47-Year-Old Man
Posted in Misc. DrugsAn article published in the February, 2013 edition of The American Journal of the Medical Sciences by Dr. John C. Winton et al. describes the case of a man, aged 47 years, who suffered sudden cardiac arrest after azithromycin (Zithromax Z-Pak) was added to other medications he was using.[1] This article, showing the danger of… Continue Reading
Zithromax Z-Pak Dramatically Raises Risk of Cardiovascular Death
Posted in Misc. DrugsRecently, an article published in The New England Journal of Medicine by Dr. Wayne A. Ray et al. titled “Azithromycin and the Risk of Cardiovascular Death” reveals the danger of a widely-used antibiotic azithromycin (Zithromax Z-Pak), demonstrating that the use of this drug dramatically increases the risk of cardiovascular death.[1] This article studied thousands of… Continue Reading
Sequester may or may not slow down approvals of generic drugs
Posted in Generic Drugs, PoliticsCould go either way. Probably won’t have any effect on whether or not injured consumers can sue if they took generics. Hamburg said FDA has collected $125 million in GDUFA fees for 2013 so far. However, she noted, the budget situation and sequestration have “significant implications” for using generic user fees and budget dollars. Budget… Continue Reading
Waxman says that the Hatch-Waxman act does not preclude generic liability
Posted in Generic DrugsScalia fans everywhere will cringe at the thought of using an amicus brief filed by Waxman on this issue, but setting that prejudice aside, this is kind of a big deal: Here’s even more powerful evidence of Congress’s intent: a newly filed amicus brief filed by Senator Tom Harkin (D-Iowa) and Representative Henry Waxman (D-California,… Continue Reading
1981 – Diagnosis of IUD Migration
Posted in Misc. DrugsSince 1990, Bayer Pharmaceuticals has been marketing an intrauterine device (IUD) under the brand name Mirena®, an IUD which releases a controlled amount of the progestin levonorgestrel into the uterus daily. While this is an effective means of contraception – about as effective as oral contraceptives, intrauterine devices come with the risk for serious adverse… Continue Reading
1997 – Paxil Causes Neonatal Abstinence Syndrome
Posted in Paxil Birth Defects, UncategorizedPublished in a 1997 edition of The British Journal of Psychiatry by the medical researchers M.L. Dahl et al., a letter to the editor titled “Paroxetine withdrawal syndrome in a neonate” aimed to describe and characterize neonatal withdrawal from Paxil® addiction through exposure to the drug during gestation. This letter describes a case report, a… Continue Reading
Paxil Linked to Birth Defects
Posted in Paxil Birth DefectsIn 2007, medical researchers J. Alexander Cole et al. published a report on the increased likelihood of congenital malformations in infants whose mothers used Paxil® (paroxetine) during pregnancy and found some startling results. This study, titled “Paroxetine in the first trimester and the prevalence of congenital malformations,” published in the journal Pharmacoepidemiology and Drug Safety,… Continue Reading
Prozac-Induced Neonatal Withdrawal Syndrome
Posted in Prozac Birth DefectsPublished in a 2000 edition of the Journal of Perinatology, Dr. Chandrakala Mohan and Dr. John Moore present a case review of an infant suffering from fluoxetine (Prozac®) intoxication at birth. Prozac® is a type of antidepressant known as a selective serotonin reuptake inhibitor (SSRI) that regulates levels of serotonin in the brain, since serotonin… Continue Reading
Paxil, Prozac, Celexa Linked to Neonatal Abstinence Syndrome
Posted in Misc. Drugs, Paxil Birth Defects, Prozac Birth DefectsIn 2001, a research paper from a team based in Norway, headed by H. Nordeng, presented the results of a study titled “Neonatal withdrawal syndrome after in utero exposure to selective serotonin reuptake inhibitors [(SSRIs)],” the main conclusion of which was that “Neonatal withdrawal syndrome can occur after third trimester in utero SSRI exposure.”[1] This… Continue Reading
Prozac can cause low birth weight
Posted in Prozac Birth DefectsIn 2003, a study by Dr. Victoria Hendrick et al. titled “Birth outcomes after prenatal exposure to antidepressant medication” was published in The American Journal of Obstetrics and Gynecology, aiming to evaluate the risk for congenital malformations in infants whose mothers used antidepressant medication during pregnancy. Using many different parameters and studying different antidepressant drugs… Continue Reading
Paxil Tied to Birth Defects
Posted in Paxil Birth DefectsIn 2006, a research study by Bérard et al., a Canadian research team, titled “First Trimester Exposure to Paroxetine and Risk of Cardiac Malformations in Infants: The Importance of Dosage” was published in Birth Defects Research (Part B) that made several important conclusions about the safety of Paxil® use during pregnancy. In 1,403 infant-mother pairs… Continue Reading
Will consumers once again be able to sue generic drug manufacturers?
Posted in Generic Drugs, PreemptionLongtime readers of this (or any drug-related blog) know that the U.S. Supreme Court ruled that manufacturers of generic drugs cannot be sued for failure-to-warn claims. The ruling created a legal injustice for those injured by generic drugs. While every plaintiff’s lawyer has secretly hoped that Congress would fix the law, we’re all savvy enough… Continue Reading
2005 – Research Shows Paxil, Prozac Triple Risk for Neonatal Behavioral Syndrome
Posted in Misc. Drugs, Paxil Birth Defects, Prozac Birth Defects, Zoloft Birth DefectsPublished in a 2005 edition of the Journal of the American Medical Association, a study by Dr. Eydie L. Moses-Kolko et al., titled “Neonatal Signs After Late In Utero Exposure to Serotonin Reuptake Inhibitors,” reviews the danger posed to infants whose mothers used serotonin reuptake inhibitors (SRIs), a new type of antidepressant and anti-anxiety medication…. Continue Reading